Area of research
Infectious Diseases · Public Health, Environmental and Occupational Health
Research interest
Research focused on Ebola virus and Insulin, with related work in Lassa virus, Intensive care medicine, Placebo. Notable publications include 'Caring for Critically Ill Patients with Ebola Virus Disease. Perspectives from West Africa', 'Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial', and 'Li Wenliang, a face to the frontline healthcare worker. The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak'.
Safety and immunogenicity of a delayed booster dose of the rVSVΔG-ZEBOV-GP vaccine for prevention of Ebola virus disease: a multicentre, open-label, phase 2 randomised controlled trial
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial
Lassa Virus Infection: a Summary for Clinicians
South American Hemorrhagic Fevers: A summary for clinicians
Li Wenliang, a face to the frontline healthcare worker. The first doctor to notify the emergence of the SARS-CoV-2, (COVID-19), outbreak
Caring for Critically Ill Patients with Ebola Virus Disease. Perspectives from West Africa